ONC FY 2019 Earnings — BeOne Medicines Ltd. Revenue & Financial Results | Market Cap Arena

ONCBeOne Medicines Ltd.

$32B

FY 2019 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$428M+116.0% YoY

Gross Profit

$357M83.4% margin

Operating Income

-$960M-224.2% margin

Net Income

-$949M-221.5% margin

EPS (Diluted)

$-15.86

Cash Flow

Operating Cash Flow

-$750M

Free Cash Flow

-$909M

Stock-Based Comp.

$134M

Balance Sheet

Total Assets

$1.6B

Total Liabilities

$634M

Stockholders' Equity

$962M

Cash & Equivalents

$618M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$428M	$198M	+116.0%
Gross Profit	$357M	-$509M	+170.1%
Operating Income	-$960M	-$706M	-36.0%
Net Income	-$949M	-$674M	-40.8%